2:14 PM · 12 March 2025

Another competitor in obesity drugs market; Roche shares gain 5.5% 📈

Roche
Stocks
ROG.CH, Roche Holding AG
-
-
Zealand Pharma
Stocks
ZEAL.DK, Zealand Pharma A/S
-
-
Novo Nordisk
Stocks
NOVOB.DK, Novo Nordisk A/S
-
-
Eli Lilly
Stocks
LLY.US, Eli Lilly & Co
-
-

Roche (ROG.CH), is turning a new page in the company’s history after acquiring rights to an obesity therapy from Denmark’s Zealand Pharma (ZEAL.DK).

The deal signals a renewed push by Roche to catch up with obesity market leaders Novo Nordisk (NOVOB.DK) and Eli Lilly (LLY.US).

Under the agreement, Zealand Pharma will receive $1.65 billion upfront with the possibility of milestone payments, bringing the total to $5.3 billion, depending largely on late-stage trials and sales development, Roche said.

Zealand Pharma shares rose 26% following the announcement.

Jefferies analysts wrote in a note that they believe that Zealand Pharma's petrelintide could be better than Novo Nordisk's CagriSema, hence the nearly 4% discount in the company's shares.

Source: Distribution of rates of return in the pharmaceutical sector. Source: xStation

24 October 2025, 7:00 PM

Daily Summary: CPI down, Markets Up

24 October 2025, 6:13 PM

Procter & Gamble: After Earnings

24 October 2025, 5:36 PM

"Mad Max" mode - Is Tesla in trouble?

24 October 2025, 5:14 PM

Intel’s turnaround is showing results

Join over 1 700 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits